Reply to: "Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?"; Shinya Matsuzaki, MD, PhD, Yoshikazu Nagase, MD, Masayuki Endo, MD, PhD, Tadashi Kimura, MD, PhD

Arch Gynecol Obstet. 2022 Feb;305(2):539-541. doi: 10.1007/s00404-021-05964-5. Epub 2021 Feb 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acetylglucosaminidase*
  • Disseminated Intravascular Coagulation* / therapy
  • Female
  • Humans
  • Hysterectomy
  • Schools, Medical

Substances

  • Acetylglucosaminidase